D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 122 Citations 62,704 870 World Ranking 1399 National Ranking 845

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

Gareth J. Morgan mostly deals with Multiple myeloma, Internal medicine, Surgery, Oncology and Bone marrow. His study focuses on the intersection of Multiple myeloma and fields such as Cancer research with connections in the field of Natural killer cell. The various areas that he examines in his Internal medicine study include Gastroenterology and Pathology.

In general Surgery study, his work on Autologous stem-cell transplantation, Melphalan, Zoledronic acid and Autologous transplantation often relates to the realm of Clodronic acid, thereby connecting several areas of interest. The study incorporates disciplines such as Context, Survival rate, Cyclophosphamide, Retrospective cohort study and Hazard ratio in addition to Oncology. His Bone marrow research is included under the broader classification of Immunology.

His most cited work include:

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. (2431 citations)
  • International uniform response criteria for multiple myeloma (2049 citations)
  • International staging system for multiple myeloma. (1912 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Multiple myeloma, Oncology, Immunology and Surgery are his primary areas of study. His Internal medicine research includes themes of Gastroenterology and Cardiology. His Multiple myeloma research is multidisciplinary, incorporating perspectives in Cancer research and Bone marrow, Pathology.

His studies in Oncology integrate themes in fields like Cancer, Clinical trial, Bioinformatics and Dexamethasone. His Immunology research is mostly focused on the topic Antibody. His Thalidomide research integrates issues from Regimen, Cyclophosphamide, Maintenance therapy and Melphalan.

He most often published in these fields:

  • Internal medicine (47.86%)
  • Multiple myeloma (45.69%)
  • Oncology (23.62%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (47.86%)
  • Multiple myeloma (45.69%)
  • Oncology (23.62%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Multiple myeloma, Oncology, Cardiology and Cancer research. His studies in Lenalidomide, Transplantation, Progression-free survival, Thalidomide and Cyclophosphamide are all subfields of Internal medicine research. His Multiple myeloma research includes elements of Monoclonal gammopathy of undetermined significance, Computational biology, Bone marrow and Disease.

His Computational biology study combines topics from a wide range of disciplines, such as Gene and Whole genome sequencing. Gareth J. Morgan regularly ties together related areas like Cancer in his Bone marrow studies. His studies examine the connections between Oncology and genetics, as well as such issues in Clinical trial, with regards to Randomized controlled trial.

Between 2017 and 2021, his most popular works were:

  • The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report (592 citations)
  • Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. (149 citations)
  • A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis (125 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

His primary areas of investigation include Multiple myeloma, Internal medicine, Oncology, Transplantation and Cardiology. His Multiple myeloma research incorporates elements of Survival rate, Cancer research, Maintenance therapy and Bone marrow. His biological study spans a wide range of topics, including Cancer, Genetic heterogeneity, Gene signature and Mesenchymal stem cell.

Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. His study in Oncology is interdisciplinary in nature, drawing from both Risk stratification, Proportional hazards model and MEDLINE. Gareth J. Morgan has researched Lenalidomide in several fields, including Thalidomide and Bortezomib.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International uniform response criteria for multiple myeloma

B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade.
Leukemia (2006)

2975 Citations

International staging system for multiple myeloma.

Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley.
Journal of Clinical Oncology (2005)

2970 Citations

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie.
British Journal of Haematology (2003)

2665 Citations

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans.
Leukemia (2003)

2431 Citations

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

J. Anthony Child;Gareth J. Morgan;Faith E. Davies;Roger G. Owen.
The New England Journal of Medicine (2003)

2069 Citations

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst.
Journal of Clinical Oncology (2015)

1144 Citations

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.

Faith E. Davies;Faith E. Davies;Faith E. Davies;Noopur Raje;Noopur Raje;Noopur Raje;Teru Hideshima;Teru Hideshima;Teru Hideshima;Suzanne Lentzsch;Suzanne Lentzsch;Suzanne Lentzsch.
Blood (2001)

1123 Citations

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

R Fonseca;P L Bergsagel;J Drach;J Shaughnessy.
Leukemia (2009)

948 Citations

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel.
Leukemia (2009)

866 Citations

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson.
Leukemia (2008)

861 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gareth J. Morgan

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 377

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 372

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 342

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 308

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 275

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 263

Nikhil C. Munshi

Nikhil C. Munshi

Harvard University

Publications: 252

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 251

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 246

Robert A. Kyle

Robert A. Kyle

Mayo Clinic

Publications: 238

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 234

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 212

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 191

Martha Q. Lacy

Martha Q. Lacy

Mayo Clinic

Publications: 189

Jesús F. San Miguel

Jesús F. San Miguel

University of Navarra

Publications: 182

Pieter Sonneveld

Pieter Sonneveld

Erasmus University Rotterdam

Publications: 176

Trending Scientists

Wan Kyun Chung

Wan Kyun Chung

Pohang University of Science and Technology

Dae-Eun Kim

Dae-Eun Kim

Yonsei University

Scott A. McLuckey

Scott A. McLuckey

Purdue University West Lafayette

Hiroshi Terada

Hiroshi Terada

Tokyo University of Science

Xiaolin Li

Xiaolin Li

Pacific Northwest National Laboratory

Stanislas Lyonnet

Stanislas Lyonnet

Imagine Institute for Genetic Diseases

David J. Sherratt

David J. Sherratt

University of Oxford

Juan Carlos Izpisua Belmonte

Juan Carlos Izpisua Belmonte

Salk Institute for Biological Studies

Phyllis D. Coley

Phyllis D. Coley

University of Utah

Ziying Yan

Ziying Yan

University of Iowa

Martin Walter

Martin Walter

Leibniz Institute for Neurobiology

Cheryl L. Holt

Cheryl L. Holt

University of Maryland, College Park

Martin S. Maron

Martin S. Maron

Tufts Medical Center

Eric Mick

Eric Mick

University of Massachusetts Medical School

Harvey J. Sugerman

Harvey J. Sugerman

Virginia Commonwealth University

Markus Roth

Markus Roth

Karlsruhe Institute of Technology

Something went wrong. Please try again later.